IL34 and osteosarcoma: ,35 In cancer, using a model of osteosarcoma, Ségaliny et al. reported that IL34 promoted TAM recruitment into tumors, possibly by enhancing monocyte adhesion to activated human umbilical vein endothelial cells (HUVEC) monolayers via a CSF1R-independent mechanism.36